Development and characterization of fused human arginase I for cancer therapy.

Jawalekar, Snehal Sainath; Kawathe, Priyanka Sugriv; Sharma, Nisha; Anakha, J; Tikoo, Kulbhushan; Pande, Abhay H.

Afiliação

Jawalekar SS; Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160062, Punjab, India.
Kawathe PS; Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160062, Punjab, India.
Sharma N; Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160062, Punjab, India.
Anakha J; Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160062, Punjab, India.
Tikoo K; Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160062, Punjab, India.
Pande AH; Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, 160062, Punjab, India. apande@niper.ac.in.

Invest New Drugs ; 41(5): 652-663, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37532976